Fund profile

2048 Ventures

New York, United States

Leading

About

2048 Ventures is a venture capital firm founded in 2018 and headquartered in New York, NY. The firm focuses on early-stage investments, particularly in technology-driven startups. They have a strong portfolio with over 120 investments across diverse sectors, including biotechnology, artificial intelligence, health tech, and commercial products. Some notable companies backed by 2048 Ventures include Adaptis Technologies, an AI-powered platform for optimizing the carbon footprint of buildings, and Fathom Optics, which delivers 3D experiences using standard printing technologies. Their investment strategy is to support visionary founders at the earliest stages, often leading pre-seed and seed rounds. 2048 Ventures has shown significant activity, with their portfolio companies collectively raising $591 million and reaching a valuation of $2.6 billion by the end of 2023. They have invested in innovative companies like TwoStep Therapeutics, which specializes in modular peptide technology for targeting solid tumors, and Century Health, which leverages AI to accelerate drug development​.

Details

Highlights

$109.6k

Historical average check

$11.5M

Historical max check

November 2024

Last investment date

124

Investments

Biotech

Healthtech & Wellness

AI & Deep Tech

Hardware. Robotics & IoT

Pharma

Software & Apps

Sharing economy

E-commerce & Retail

Transportation & Mobility

Other

Funds that also invest in AI & Deep Tech